Kendra Adams C4 Therapeutics, Inc. (CCCC) insider trading activity
Kendra Adams is Chief Financial Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 165,117 shares of CCCC, which is worth approximately $392,978. The most recent transaction as insider was on Feb 14, 2025, when has been sold 4,559 shares (Common Stock) at a price of $3.18 per share, resulting in proceeds of $14,497. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
165K
95.55%
3M change
101.27%
12M change
Total Value Held
$392,978
Kendra Adams Transaction History
KA
Kendra Adams
Chief Financial Officer
Watertown, MA